Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | CA4 | P22748 | 4/20 | 0.50 |
| ▸ | CA9 | Q16790 | 4/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26094131 | 1.00 | CA1 (0.50) | CA1CA2CA4CA9SIGMAR1 | |
| SCHEMBL20974922 | 0.87 | SIGMAR1 (0.54) | CA1CA2CA4CA9SIGMAR1 | |
| SCHEMBL3495972 | 0.87 | SIGMAR1 (0.54) | CA1CA2CA4CA9SIGMAR1 | |
| SCHEMBL4971104 | 0.87 | SIGMAR1 (0.54) | CA1CA2CA4CA9SIGMAR1 | |
| SCHEMBL27533150 | 0.87 | CA1 (0.63) | CA1CA2CA4CA9 | |
| SCHEMBL3493200 | 0.86 | CA1 (0.50) | CA1CA2CA4CA9SIGMAR1 | |
| SCHEMBL23496804 | 0.84 | CA1 (0.65) | CA1CA2CA4CA9SIGMAR1 | |
| SCHEMBL29111200 | 0.84 | CA1 (0.65) | CA1CA2CA4CA9SIGMAR1 | |
| SCHEMBL29247571 | 0.82 | GPR119 (0.47) | CA1CA2CA4CA9ALDH1A1 | |
| SCHEMBL25532990 | 0.82 | GPR119 (0.47) | CA1CA2CA4CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023067353-A1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | ARTIOS PHARMA LIMITED (GB) | 2023-04-27 | — | — | WO | disclosed |